YCM
RGNX icon

Yousif Capital Management’s Regenxbio RGNX Stock Holding History

Yousif Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,476
Closed -$152K – 1948
2024
Q3 		$152K Hold
14,476
– – ﹤0.01% 1890
2024
Q2 		$169K Sell
14,476
-520
-3% -$8.09K ﹤0.01% 1858
2024
Q1 		$316K Sell
14,996
-1,640
-10% -$29.2K ﹤0.01% 1716
2023
Q4 		$299K Sell
16,636
-2,965
-15% -$52.2K ﹤0.01% 1752
2023
Q3 		$323K Sell
19,601
-270
-1% -$4.89K ﹤0.01% 1676
2023
Q2 		$397K Sell
19,871
-1,535
-7% -$29.6K ﹤0.01% 1596
2023
Q1 		$405K Sell
21,406
-4,207
-16% -$93.1K 0.01% 1578
2022
Q4 		$581K Sell
25,613
-3,415
-12% -$77.2K 0.01% 1434
2022
Q3 		$767K Sell
29,028
-598
-2% -$17.7K 0.01% 1326
2022
Q2 		$732K Sell
29,626
-3,035
-9% -$75.8K 0.01% 1385
2022
Q1 		$1.08M Buy
32,661
+1,488
+5% +$41.3K 0.01% 1320
2021
Q4 		$1.02M Buy
+31,173
New +$1.06M 0.01% 1360

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Yousif Capital Management's RGNX Position: Q4 2024 in Review

Yousif Capital Management sold out of Regenxbio (RGNX) in Q4 2024, closing a stake of 14,476 shares — an estimated $152K sold.

Yousif Capital Management first reported a position in RGNX in Q4 2021 and held it in 12 quarters. The position peaked at $1.08M in Q1 2022. 177 funds tracked by Wall St. Rank hold RGNX as of Q4 2024.

  • Yousif Capital Management reported no remaining Regenxbio position as of Q4 2024 after selling out during the quarter.
  • Yousif Capital Management sold 14,476 Regenxbio shares in Q4 2024, an estimated $152K.
  • Yousif Capital Management first reported a position in Regenxbio in Q4 2021 and held it in 12 quarters.
  • Yousif Capital Management's Regenxbio position peaked at $1.08M in Q1 2022.
  • 177 funds tracked by Wall St. Rank held Regenxbio as of Q4 2024.

Based on Yousif Capital Management's 13F filing for Q4 2024, filed 27 Jan 2025.